Annual SG&A
$4.18 M
-$1.17 M-21.81%
31 December 2023
Summary:
Avenue Therapeutics annual selling, general & administrative expenses is currently $4.18 million, with the most recent change of -$1.17 million (-21.81%) on 31 December 2023. During the last 3 years, it has risen by +$1.70 million (+68.24%). ATXI annual SG&A is now -21.81% below its all-time high of $5.34 million, reached on 31 December 2022.ATXI Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$829.00 K
-$633.00 K-43.30%
30 September 2024
Summary:
Avenue Therapeutics quarterly selling, general & administrative expenses is currently $829.00 thousand, with the most recent change of -$633.00 thousand (-43.30%) on 30 September 2024. Over the past year, it has dropped by -$308.00 thousand (-27.09%). ATXI quarterly SG&A is now -75.38% below its all-time high of $3.37 million, reached on 31 December 2022.ATXI Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$385.19 M
-$9.47 M-2.52%
30 September 2024
Summary:
Avenue Therapeutics TTM selling, general & administrative expenses is currently -$385.19 million, with the most recent change of -$9.47 million (-2.52%) on 30 September 2024. Over the past year, it has dropped by -$389.37 million (-9319.53%). ATXI TTM SG&A is now -4483.98% below its all-time high of $6.41 million, reached on 30 September 2023.ATXI TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATXI Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -27.1% | -9319.5% |
| 3 y3 years | +68.2% | +58.2% | -10000.0% |
| 5 y5 years | +36.1% | +33.9% | -10000.0% |
ATXI Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -21.8% | +68.2% | -75.4% | +82.6% | -27.3% | at low |
| 5 y | 5 years | -21.8% | +78.1% | -75.4% | +82.6% | -57.4% | at low |
| alltime | all time | -21.8% | +319.2% | -75.4% | +314.5% | -4484.0% | at low |
Avenue Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $829.00 K(-43.3%) | $4.74 M(-6.5%) |
| June 2024 | - | $1.46 M(+11.1%) | $5.08 M(+12.5%) |
| Mar 2024 | - | $1.32 M(+15.7%) | $4.51 M(+7.9%) |
| Dec 2023 | $4.18 M(-21.8%) | $1.14 M(-2.1%) | $4.18 M(-34.8%) |
| Sept 2023 | - | $1.16 M(+29.6%) | $6.41 M(+12.1%) |
| June 2023 | - | $896.00 K(-8.9%) | $5.72 M(+8.4%) |
| Mar 2023 | - | $984.00 K(-70.8%) | $5.27 M(-1.3%) |
| Dec 2022 | $5.34 M(+115.2%) | $3.37 M(+617.9%) | $5.34 M(+113.6%) |
| Sept 2022 | - | $469.00 K(+3.3%) | $2.50 M(-4.8%) |
| June 2022 | - | $454.00 K(-57.0%) | $2.63 M(-6.0%) |
| Mar 2022 | - | $1.05 M(+101.3%) | $2.80 M(+12.6%) |
| Dec 2021 | $2.48 M(+5.8%) | $524.00 K(-11.8%) | $2.48 M(+0.4%) |
| Sept 2021 | - | $594.00 K(-4.7%) | $2.48 M(+0.9%) |
| June 2021 | - | $623.00 K(-16.2%) | $2.45 M(-2.4%) |
| Mar 2021 | - | $743.00 K(+44.3%) | $2.51 M(+7.1%) |
| Dec 2020 | $2.35 M | $515.00 K(-9.8%) | $2.35 M(-4.2%) |
| Sept 2020 | - | $571.00 K(-16.5%) | $2.45 M(-1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $684.00 K(+18.5%) | $2.50 M(-1.3%) |
| Mar 2020 | - | $577.00 K(-6.8%) | $2.53 M(-17.6%) |
| Dec 2019 | $3.07 M(-25.5%) | $619.00 K(+0.3%) | $3.07 M(-20.0%) |
| Sept 2019 | - | $617.00 K(-13.8%) | $3.84 M(-5.0%) |
| June 2019 | - | $716.00 K(-36.0%) | $4.04 M(-5.0%) |
| Mar 2019 | - | $1.12 M(-19.3%) | $4.25 M(+3.2%) |
| Dec 2018 | $4.12 M(+13.8%) | $1.39 M(+69.1%) | $4.12 M(+7.4%) |
| Sept 2018 | - | $820.00 K(-11.5%) | $3.84 M(-0.7%) |
| June 2018 | - | $927.00 K(-6.0%) | $3.87 M(-8.7%) |
| Mar 2018 | - | $986.00 K(-10.7%) | $4.24 M(+17.0%) |
| Dec 2017 | $3.62 M(+263.1%) | $1.10 M(+30.2%) | $3.62 M(+28.4%) |
| Sept 2017 | - | $848.00 K(-34.6%) | $2.82 M(+29.8%) |
| June 2017 | - | $1.30 M(+249.6%) | $2.17 M(+98.9%) |
| Mar 2017 | - | $371.00 K(+22.0%) | $1.09 M(+9.5%) |
| Dec 2016 | $997.00 K | $304.00 K(+52.0%) | $997.00 K(+43.9%) |
| Sept 2016 | - | $200.00 K(-7.8%) | $693.00 K(+40.6%) |
| June 2016 | - | $217.00 K(-21.4%) | $493.00 K(+78.6%) |
| Mar 2016 | - | $276.00 K | $276.00 K |
FAQ
- What is Avenue Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Avenue Therapeutics?
- What is Avenue Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Avenue Therapeutics?
- What is Avenue Therapeutics quarterly SG&A year-on-year change?
- What is Avenue Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Avenue Therapeutics?
- What is Avenue Therapeutics TTM SG&A year-on-year change?
What is Avenue Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of ATXI is $4.18 M
What is the all time high annual SG&A for Avenue Therapeutics?
Avenue Therapeutics all-time high annual selling, general & administrative expenses is $5.34 M
What is Avenue Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of ATXI is $829.00 K
What is the all time high quarterly SG&A for Avenue Therapeutics?
Avenue Therapeutics all-time high quarterly selling, general & administrative expenses is $3.37 M
What is Avenue Therapeutics quarterly SG&A year-on-year change?
Over the past year, ATXI quarterly selling, general & administrative expenses has changed by -$308.00 K (-27.09%)
What is Avenue Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of ATXI is -$385.19 M
What is the all time high TTM SG&A for Avenue Therapeutics?
Avenue Therapeutics all-time high TTM selling, general & administrative expenses is $6.41 M
What is Avenue Therapeutics TTM SG&A year-on-year change?
Over the past year, ATXI TTM selling, general & administrative expenses has changed by -$389.37 M (-9319.53%)